Top Story

Mount Sinai names vice chairman of urology

October 14, 2014

Ketan Badani, MD, professor of urology at Icahn School of Medicine at Mount Sinai, has been named vice chairman of urology and robotic operations at Mount Sinai Health System.

Badani also will serve as director of the health system’s kidney cancer program, as well as director of robotic surgery at Mount Sinai St. Luke’s and Mount Sinai Roosevelt.

figure In the Journals

Radical cystectomy, urinary diversion increased fracture risk among patients with bladder cancer

October 8, 2014
Patients with bladder cancer who underwent radical cystectomy and urinary diversion demonstrated an increased risk for bone fracture, according to results of a…
figure EditorialPublication Exclusive

Not again … but I thought the government and Pharma said the problem was fixed?

HemOnc Today, October 25, 2014
Derek Raghavan, MD, PhD
Bladder cancer is one of the commonest malignancies in Western society.There are more than 75,000 new cases each year in the United States, and about 80% of incident…
figure In the JournalsPerspective

Multidisciplinary approach may better detect, treat depression among patients with cancer

HemOnc Today, October 25, 2014
Major depression is common among patients with cancer — particularly those with lung cancer — yet it often goes untreated, according to a series of studies published by…
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »

Filter By:

Institution Notes

Mount Sinai names vice chairman of urology

October 14, 2014
Ketan Badani, MD, professor of urology at Icahn School of Medicine at Mount Sinai, has been named vice chairman of urology and robotic operations at…
figure In the Journals

Radical cystectomy, urinary diversion increased fracture risk among patients with bladder cancer

October 8, 2014
Patients with bladder cancer who underwent radical cystectomy and urinary diversion demonstrated an increased risk for bone fracture, according to…
figure Editorial Publication Exclusive

Not again … but I thought the government and Pharma said the problem was fixed?

HemOnc Today, October 25, 2014
Derek Raghavan, MD, PhD
Bladder cancer is one of the commonest malignancies in Western society.There are more than 75,000 new cases each year in the United States, and about…
figure In the Journals Perspective

Multidisciplinary approach may better detect, treat depression among patients with cancer

HemOnc Today, October 25, 2014
Major depression is common among patients with cancer — particularly those with lung cancer — yet it often goes untreated, according to a series of…
Meeting News Coverage

Safety, efficacy of sorafenib exposure inconsistent in HCC, RCC patients

September 29, 2014
There was no apparent relationship between exposure to sorafenib and safety and efficacy among patients with hepatocellular carcinoma or renal cell…
In the Journals

Zoledronic acid plus everolimus improved outcomes in renal cell carcinoma

September 26, 2014
The addition of zoledronic acid to everolimus significantly reduced bone resorption markers and extended tumor control in patients with renal cell…
figure Editorial Publication Exclusive

I’d like to agree with you … but then we’d both be wrong!

HemOnc Today, September 25, 2014
Derek Raghavan, MD, PhD
I sometimes fear that I am a natural curmudgeon, or at the very least a true cynic.If you have read my recent editorials and op-eds, it may seem I…
figure Meeting News Coverage Perspective

Shorter ADT regimen improved quality of life among men with high-risk prostate cancer

September 16, 2014
Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved…
figure

Report: Commitment to NIH, NCI funding only 'viable path' for continued success in cancer research

September 16, 2014
The scientific community’s continued quest to prevent and cure cancer has reached a crossroads, according to a report released today by the…
Meeting News Coverage Perspective

High-dose radiation plus long-term ADT extended survival in prostate cancer

September 15, 2014
Men with intermediate or high-risk prostate cancer who underwent high-dose radiation therapy followed by a longer duration of androgen deprivation…
More Headlines »